COGT EBITDA Growth
Cogent Biosciences Inc · EBITDA Growth
COGT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-33.34%period ending
COGT TTM EBITDA YoY % (-15.42% → -33.34%)
Year-over-year change
High-resolution chart · PNG
COGT ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -33.3364% | |
| -32.0269% | |
| -29.5517% | |
| -20.8969% | |
| -25.0894% | |
| -27.2925% | |
| -33.1985% | |
| -36.9846% | |
| -48.087% | |
| -45.9019% | |
| -39.4271% | |
| -43.0479% | |
| -37.9602% | |
| -56.8762% | |
| -85.0146% | |
| -103.3516% | |
| -114.5845% | |
| -119.1972% | |
| -111.7446% | |
| -190.5958% | |
| -130.2309% | |
| -64.6301% | |
| -12.5049% | |
| 50.4607% | |
| 44.8013% | |
| 35.3132% | |
| 10.3813% | |
| -27.3874% | |
| -37.0933% | |
| -50.7037% | |
| -37.2483% | |
| -17.5901% | |
| -15.4217% |